Michael Chuang
2 Papers
Michael Chuang is an academic researcher. The author has contributed to research in topics: Mitral valve & Mitral regurgitation. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial
David W.M. Muller,Robert S. Farivar,Paul Jansz,Richard Bae,Darren L. Walters,Andrew Clarke,Paul A. Grayburn,Robert C. Stoler,Gry Dahle,Kjell Arne Rein,Marty Shaw,Gregory M. Scalia,Mayra Guerrero,Paul J. Pearson,Samir R. Kapadia,Marc Gillinov,Augusto D. Pichard,Paul J. Corso,Jeffrey J. Popma,Michael Chuang,Philipp Blanke,Jonathon Leipsic,Paul Sorajja,Tendyne Global Feasibility Trial Investigators +23 more
TL;DR: Transcatheter mitral valve replacement (TMVR) is an effective and safe therapy for selected patients with symptomatic native MR and may help address an unmet need in patients at high risk for cardiac surgery.
235
Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation.
Vinay Badhwar,Paul Sorajja,Alison Duncan,Vinod H. Thourani,Ulrich Schaefer,Paul A. Grayburn,Nicolas Dumonteil,Vasilis Babaliaros,Andrea Garatti,Jonathon Leipsic,Michael Chuang,Philipp Blanke,David W.M. Muller +12 more
TL;DR: Preoperative severe MR was predictive of improved 1-year outcome following transcatheter mitral valve implantation with the Tendyne device, and may inform a therapeutic gap for the management of secondary MR and left ventricular dilatation.
23